Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primitive neuroectodermal tumors/medulloblastoma.

Michael D Weil1

  • 1Sirius Medicine, LLC, 584 West Douglas Road, Fort Collins, CO 80524, USA. mweil@frii.com

Current Neurology and Neuroscience Reports
|April 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-coplanar lung SABR treatments delivered with a gantry-mounted x-ray tube.

Physics in medicine and biology·2023
Same author

Dosimetry of a novel converging X-ray source for kilovoltage radiotherapy.

Medical physics·2021
Same author

External beam radiation therapy with kilovoltage x-rays.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2020
Same author

Inverse optimization of low-cost kilovoltage x-ray arc therapy plans.

Medical physics·2018
Same author

Monte Carlo simulations of a kilovoltage external beam radiotherapy system on phantoms and breast patients.

Medical physics·2017
Same author

Feasibility of external beam radiation therapy to deep-seated targets with kilovoltage x-rays.

Medical physics·2017
Same journal

The Noradrenergic Brain in Parkinson's Disease.

Current neurology and neuroscience reports·2026
Same journal

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

Current neurology and neuroscience reports·2026
Same journal

Functional and Structural Brain Imaging Correlates of Treatment Response in Functional Movement Disorder.

Current neurology and neuroscience reports·2026
Same journal

Astrocytopathy in Wernicke Encephalopathy and Neuromyelitis Optica Spectrum Disorder. Pathogenic Differences With Occasional Clinical and Neuroimaging Overlap. A Review.

Current neurology and neuroscience reports·2026
Same journal

When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?

Current neurology and neuroscience reports·2026
Same journal

Assessment and Management of Post-traumatic Headache.

Current neurology and neuroscience reports·2026
See all related articles

Standard medulloblastoma treatment involves surgery and toxic chemo-radiotherapy across the entire craniospinal axis. Research into genetic factors for medulloblastoma (primitive neuroectodermal tumors) is ongoing but not yet clinically applicable.

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Cancer Genetics

Background:

  • Medulloblastoma and primitive neuroectodermal tumors (PNTs) of the central nervous system (CNS) are aggressive pediatric brain cancers.
  • Current standard therapy involves surgery followed by intensive combination chemo-radiotherapy targeting the entire craniospinal axis.
  • This aggressive treatment regimen is lengthy and associated with significant toxicity, particularly in infants who may avoid full craniospinal irradiation.

Purpose of the Study:

  • To summarize the current therapeutic landscape for CNS medulloblastoma/PNTs.
  • To highlight the challenges and toxicities associated with standard treatment protocols.
  • To underscore the need for less toxic and more targeted therapeutic strategies.

Main Methods:

Related Experiment Videos

  • Review of standard treatment protocols for medulloblastoma/PNTs.
  • Discussion of the rationale behind craniospinal axis radiation.
  • Consideration of patient stratification based on clinical disease evidence.
  • Overview of ongoing basic research into genetic factors.

    • Main Results:

    • Surgery followed by combination chemo-radiotherapy is the established treatment paradigm.
    • Craniospinal axis radiation is a key component, with exceptions for infants.
    • Treatment duration and toxicity are significant concerns.
    • Early-stage research is identifying genetic drivers, but clinical translation is pending.

    Conclusions:

    • Current medulloblastoma/PNT therapy is effective but burdensome.
    • There is a critical need for treatment de-escalation strategies for select patients.
    • Advancements in understanding the genetic basis of these tumors hold promise for future targeted therapies.